Director/PDMR Dealings
Tweet
Share
E-mail25 NOVEMBER 2025
NORTHERN 2 VCT PLC
DIRECTOR/PDMR DEALINGS
Northern 2 VCT PLC (“the Company”) has been notified that in respect of the allotment of new ordinary shares pursuant to the Prospectus dated 17 September 2025, the following PDMR acquired ordinary shares of 5 pence each in the Company.
| PDMR | Date acquired | No. of shares acquired | Purchase price per share (£) | Total current shareholding |
| Thomas Chambers | 25 November 2025 | 49,204 | 0.5894 | 96,195 |
These notifications are made in accordance with the Market Abuse Regulations.
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |
| a) | Name | Thomas Chambers |
| 2 | Reason for the notification | |
| a) | Position / status | Director (PDMR) |
| b) | Initial notification / amendment | Initial notification |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
| a) | Name | Northern 2 VCT PLC |
| b) | LEI | 213800K2EJ4CM6G9K687 |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a) | Description of the financial instrument, type of instrument Identification code | Ordinary Shares of 5p each GB0005356430 |
| b) | Nature of the transaction | Allotment of new ordinary shares pursuant to the Prospectus dated 17 September 2025 |
| c) | Price(s) and volume(s) | Price(s) £0.5894 Volume(s) 49,204 |
| d) | Aggregated information - Aggregated volume - Price | N/A - single transaction |
| e) | Date of the transaction | 25 November 2025 |
| f) | Place of the transaction | XLON |
Enquiries:
Sarah Williams / James Sly, Mercia Fund Management Limited - 0330 223 1430
Website: www.mercia.co.uk/vcts
The contents of the Mercia Asset Management PLC website and the contents of any website accessible from hyperlinks on the Mercia Asset Management PLC website (or any other website) are not incorporated into, nor form part of, this announcement.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 4DMT Announces Positive 2-Year Data from PRISM Phase 2b Clinical Trial in a Broad Wet AMD Population
- New to The Street(R) to Broadcast Show #762 Tonight on Bloomberg Television at 6:30 PM ET, Featuring Envoy Medical (NASDAQ:COCH), AlphaCompute (NASDAQ:ALP), RHINO Bitcoin (OTC PINK:RHNO), and Big Sky
- REGENXBIO Presents Positive Long-Term Data for Surabgene Lomparvovec in Wet AMD and Diabetic Retinopathy at American Society of Retina Specialists Annual Meeting
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
